Your session is about to expire
← Back to Search
Protective Cooling Measures for Heat Stress in the Elderly
N/A
Waitlist Available
Led By Ronald J Sigal, MD, MPH
Research Sponsored by University of Ottawa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult aged 60-85 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8-hour heat exposure
Awards & highlights
Study Summary
This trial will assess whether shorter but more frequent air-conditioning exposure provides more effective cooling than current recommendations in older adults with or without common chronic health conditions.
Who is the study for?
This trial is for adults aged 60-85 with high blood pressure or Type 2 diabetes, but not severe related complications. They should have a BMI under 35 and can't be smokers or heat-adapted from saunas or travel to hot climates.Check my eligibility
What is being tested?
The study tests cooling strategies against summer heat for the elderly. It compares no cooling, recommended long-duration cooling, and shorter more frequent cooling sessions during simulated extreme heat conditions.See study design
What are the potential side effects?
Since this trial involves non-invasive interventions like exposure to air conditioning as a form of cooling, there are minimal expected side effects compared to medicinal trials.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 60 and 85 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8-hour heat exposure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8-hour heat exposure
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Core temperature (AUC)
Core temperature (peak)
Secondary outcome measures
Arterial blood pressures
Baroreflex sensitivity
Body fluid loss
+9 moreTrial Design
3Treatment groups
Experimental Treatment
Group I: Extreme heat event simulation + recommended coolingExperimental Treatment1 Intervention
Adults aged 60-85 years with or without type 2 diabetes and/or hypertension
Group II: Extreme heat event simulation + no cooling (control)Experimental Treatment1 Intervention
Adults aged 60-85 years with or without type 2 diabetes and/or hypertension
Group III: Extreme heat event simulation + hybrid coolingExperimental Treatment1 Intervention
Adults aged 60-85 years with or without type 2 diabetes and/or hypertension
Find a Location
Who is running the clinical trial?
University of OttawaLead Sponsor
210 Previous Clinical Trials
268,132 Total Patients Enrolled
7 Trials studying Heat Stress
157 Patients Enrolled for Heat Stress
Ronald J Sigal, MD, MPHPrincipal InvestigatorUniversity of Calgary
5 Previous Clinical Trials
173 Total Patients Enrolled
4 Trials studying Heat Stress
113 Patients Enrolled for Heat Stress
Robert D Meade, PhDPrincipal InvestigatorUniversity of Ottawa
1 Previous Clinical Trials
18 Total Patients Enrolled
1 Trials studying Heat Stress
18 Patients Enrolled for Heat Stress
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 60 and 85 years old.Your body mass index is less than 35 kg/m2.I am either male or female.I am used to hot environments due to frequent exposure.You are a smoker or have quit smoking less than 5 years ago.I have type 2 diabetes with unstable blood sugar levels and severe nerve damage.I was diagnosed with type 2 diabetes over a year ago and my A1c is between 6.0-10.5%.I have no serious health issues apart from Type 2 diabetes or high blood pressure.I was diagnosed with high blood pressure over a year ago or my average blood pressure is over 140/90.
Research Study Groups:
This trial has the following groups:- Group 1: Extreme heat event simulation + recommended cooling
- Group 2: Extreme heat event simulation + hybrid cooling
- Group 3: Extreme heat event simulation + no cooling (control)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger